Precipio, Inc. Aktie News

NEW HAVEN, Conn., 28. Okt. 2026 (GLOBE NEWSWIRE) -- Das Spezialunternehmen für Krebsdiagnostik Precipio, Inc. (NASDAQ: PRPO), veranstaltet seine Q3-2026-Aktionärs-Update-Telefonkonferenz am 10. November 2026 um 17:00 Uhr ET.

Der Umsatz erreicht ein Quartalsrekord, während Precipio zur positiven Adjusted EBITDA zurückkehrt und die Cash-Position stärkt Der Umsatz erreicht ein Quartalsrekord, während Precipio zur positiven Adjusted EBITDA zurückkehrt und die Cash-Position stärkt

NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.   (NASDAQ: PRPO) , will be hosting its Q2-2026 shareholder update call on August 17th, 2026, at 5:00 PM ET.

NEW HAVEN, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately. Votes must be received by 11:59 p.m., Eastern Time, on June 14, 2026, to be voted at the Annual Meeting.

Stable revenue performance driven by timing dynamics; expanding product pipeline expected to drive second-half growth Stable revenue performance driven by timing dynamics; expanding product pipeline expected to drive second-half growth

NEW HAVEN, Conn., May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) announces that 2025 employee stock options granted to certain members of Precipio's management team vested last week because the Company's Common Stock price increased by more than 400% since the options were granted.